ArticleNature communications2016

Corrigendum: TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer.

Rajat Banerjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.